Nivolumab in patients with rare head and neck carcinomas: A single center’s experience

Title
Nivolumab in patients with rare head and neck carcinomas: A single center’s experience
Authors
Keywords
Head and neck cancer, Adenoid cystic carcinoma, Mucoepidermoid carcinoma, Salivary gland cancer, Immunotherapy, Nivolumab, PD-1 inhibitor
Journal
ORAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-07-10
DOI
10.1016/j.oraloncology.2019.07.002

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now